Loading...
Ezetimibe
India Pharmaceutical Trade Intelligence
Who Supplies Ezetimibe to India from CHINA
India's ezetimibe imports from CHINA total $10.8K across 14 shipments from 4 foreign suppliers. PFIZER PHARMACEUTICALS LIMITED leads with $10.1K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include MYLAN LABORATORIES LIMITED. This corridor reflects India's pharmaceutical import demand for ezetimibe — a diversified sourcing base with multiple active suppliers from CHINA.
Top foreign suppliers (CHINA) — Ranked by import value
PFIZER PHARMACEUTICALS LIMITED is the leading Ezetimibe supplier from CHINA to India, with import value of $10.1K across 10 shipments. The top 5 suppliers — PFIZER PHARMACEUTICALS LIMITED, AUROVITAS PHARMA TAIZHOU CO LTD, LINHAI TIANYU PHARMACEUTICAL CO LTD, M/S WUXI YUEYUAN TECHNOLOGY CO — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (CHINA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PFIZER PHARMACEUTICALS LIMITED | $10.1K | 10 | 93.5% |
| 2 | AUROVITAS PHARMA TAIZHOU CO LTD | $559 | 2 | 5.2% |
| 3 | LINHAI TIANYU PHARMACEUTICAL CO LTD | $132 | 1 | 1.2% |
| 4 | M/S WUXI YUEYUAN TECHNOLOGY CO | $6 | 1 | 0.1% |
Showing top 4 of 4 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from CHINA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED | $10.1K | 10 | 93.5% |
| 2 | AXIS CLINICALS LIMITED | $559 | 2 | 5.2% |
| 3 | ALTHERA LABORATORIES INDIA PRIVATE LIMITED | $132 | 1 | 1.2% |
| 4 | AUROBINDO PHARMA LTD | $6 | 1 | 0.1% |
Import Statistics
- Import Value
- $10.8K
- Shipments
- 14
- Foreign Suppliers
- 4
- Indian Buyers
- 4
- Avg. Shipment
- $771
Other Ezetimibe Import Origins
Frequently Asked Questions — Ezetimibe Imports from CHINA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Ezetimibe suppliers from CHINA to India?
The top Ezetimibe suppliers from CHINA to India include PFIZER PHARMACEUTICALS LIMITED, AUROVITAS PHARMA TAIZHOU CO LTD, LINHAI TIANYU PHARMACEUTICAL CO LTD. The leading supplier is PFIZER PHARMACEUTICALS LIMITED with import value of $10.1K USD across 10 shipments. India imported Ezetimibe worth $10.8K USD from CHINA in total across 14 shipments.
QHow much Ezetimibe does India import from CHINA?
India imported Ezetimibe worth $10.8K USD from CHINA across 14 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Ezetimibe from CHINA?
The main Indian buyers of Ezetimibe sourced from CHINA include MYLAN LABORATORIES LIMITED, AXIS CLINICALS LIMITED, ALTHERA LABORATORIES INDIA PRIVATE LIMITED. The largest buyer is MYLAN LABORATORIES LIMITED with $10.1K in imports across 10 shipments.
QWhat is the total value of Ezetimibe imports from CHINA to India?
The total value of Ezetimibe imports from CHINA to India is $10.8K USD, across 14 shipments and 4 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: CHINA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Ezetimibe.
- 2.Supplier/Buyer Matching: 4 foreign suppliers from CHINA and 4 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $10.8K aggregated from 14 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
14 Verified Shipments
4 suppliers, 4 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists